FIELD: cellular biology, biophysics. SUBSTANCE: invention proposes cytotoxic composition for damage of target- cells consisting of component for recognition of target-cells and realization by them receptor-mediated endocytosis, component for directed intracellular transport into nucleus, component-carrier for assembling and stabilization of composition and properly damaging agent astatine-211 bound with protein moiety of composition in the ratio providing the cytotoxic effect. Prepared specific species of the composition characterizing by structure (modified sequence of signal of nucleus localization of T-antigen SV-40 component for intracellular transport) - (β--galactosidase-carrier) (insulin component for recognition and endocytosis) (astatine-211) and by ratio astatine-211/protein that is sufficient for preparing the composition with specific radioactivity 5 MBq/mg, not less, allows owing to the directed effect to obtain the expressed cytotoxic effect (in part, in cells of liver hepatoma) in using the preparation with specific activity by about 10 times lesser as in the case of free radionuclide. Invention provides possibility for damage of cells of definite type, for example, tumor cells in relatively low concentrations of radionuclide and minimal effect on surrounding tissues. Invention can be used in medicinal practice and pharmacology. EFFECT: enhanced effectiveness, valuable properties of composition. 6 cl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR IMAGING AND DAMAGING OF TARGET CELLS | 2015 |
|
RU2611653C1 |
COMPOSITION FOR PHOTODYNAMIC TARGET-CELL IMPAIRMENT AND A METHOD OF PHOTODYNAMIC TARGET-CELL IMPAIRMENT | 1996 |
|
RU2066552C1 |
TOOL FOR CUTTING DOUBLE-STRANDED DNA USING CAS12D PROTEIN FROM KATANOBACTERIA AND HYBRID RNA PRODUCED BY FUSION OF GUIDE CRISPR RNA AND SCOUT RNA | 2020 |
|
RU2771626C1 |
DNA-CUTTING AGENT BASED ON THE Cas9 PROTEIN FROM THE BACTERIUM CAPNOCYTOPHAGA OCHRACEA | 2021 |
|
RU2778156C1 |
ANTIBODY SPECIFICALLY BINDING WITH MUC1 AND ITS APPLICATION | 2018 |
|
RU2746413C1 |
CD3-SPECIFIC BINDING MOLECULES | 2020 |
|
RU2826453C2 |
PRODUCTION OF CONSTRUCTED CELLS FOR ADOPTIVE CELL THERAPY | 2017 |
|
RU2780156C2 |
BISPECIFIC ANTIGEN-BINDING POLYPEPTIDES | 2015 |
|
RU2723940C2 |
LIGAND BINDING RECEPTOR STEM OF POLYMERIC IMMUNOGLOBULIN (PIGR) OF CELL SPECIFICALLY, METHOD OF INCORPORATION OF LIGAND IN CELL AND METHOD OF ATTACHMENT OF LIGAND TO CELL EXPRESSING RECEPTOR OF POLYMERIC IMMUNOGLOBULIN | 1997 |
|
RU2191781C2 |
RECEPTOR FOR VISTA | 2019 |
|
RU2812846C2 |
Authors
Dates
2003-12-20—Published
2002-05-23—Filed